ADRs End Mostly Lower

By Imani Moise Features Dow Jones Newswires

International stocks trading in New York closed lower on Wednesday.

Continue Reading Below

GlaxoSmithKline PLC (GSK.LN) and America Movil SAB (AMX) were among the companies with ADRs that traded actively.

The BNY Mellon index of American depositary receipts fell 0.6% to 149.13. The European index decreased 0.5% to 138.62, the Asian index dropped 0.8% to 173.81, the Latin American index was down fractionally to 253.63 and the emerging markets index declined 0.6% to 321.82.

ADRs of GlaxoSmithKline fell 5.7% to $38.19 after management raised concerns that the company's interest in Pfizer Inc.'s (PFE) over-the-counter business could put its dividend at risk.

ADRs of America Movil declined 6.2% to $17.81 as the company continued to struggle to restore service in Puerto Rico after Hurricane Maria.

ADRs of Novartis AG (NVS) dropped 2.1% to $81.37 after being downgraded by Barclays.

Continue Reading Below

ADRs of Lloyds Banking Group PLC (LYG) rose 1.4% to $3.66 after the company reported that third-quarter pretax profit more than doubled on year and raised its financial targets for 2017.

Write to Imani Moise at imani.moise@wsj.com

International stocks trading in New York closed mostly lower on Thursday.

Nokia Corp. (NOK) and Anheuser-Busch Inbev NV (BUD) were among the companies with ADRs that traded actively.

The BNY Mellon index of American depositary receipts fell 0.4% to 148.55. The European index decreased 0.5% to 137.88, the Latin American index fell 1.8% to 248.98 and the emerging markets index declined 0.9% to 319.04. The Asian index increased 0.2% to 174.17.

ADRs of Nokia plunged 21% to $4.76 after it reported a wider third-quarter net loss and warned of a tough 2018 as it battles fierce Chinese competition and an industry-wide spending slump.

ADRs of STMicroelectronics NV (STM) jumped 10% to $23.08 after strong third-quarter results beat expectations, with its imaging division being a surprising standout.

ADRs of Anheuser-Busch InBev fell 1% to $120.41 as sales of Bud Light and Budweiser continue to lose fizz faster than the world's biggest brewer can slash costs.

Write to Austen Hufford at austen.hufford@wsj.com

(END) Dow Jones Newswires

October 26, 2017 19:38 ET (23:38 GMT)